Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer
Sign Up to like & getrecommendations! Published in 2017 at "Oncoimmunology"
DOI: 10.1080/2162402x.2016.1259050
Abstract: ABSTRACT There is a critical unmet clinical need for bladder cancer immunotherapies capable of inducing durable antitumor immunity. We have shown that four intravesical treatments with a simple co-formulation of interleukin-12 and the biopolymer chitosan… read more here.
Keywords: bladder cancer; immunological mechanisms; bladder; chitosan interleukin ... See more keywords